首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardiorenal medicine

缩写:CARDIORENAL MED

ISSN:1664-3828

e-ISSN:1664-5502

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引342
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ismail Kocyigit,Serpil Taheri,Eray Eroglu et al. Ismail Kocyigit et al.
Background and objectives: Cyst pressure induces renin-angiotensin-aldosterone system activation and kidney hypoxia in autosomal dominant polycystic kidney disease (ADPKD). Lipopolysaccharide-induced Toll-like receptor ac...
Anna Clementi,Grazia Maria Virzì,Giovanni Giorgio Battaglia et al. Anna Clementi et al.
"Organ crosstalk" is the complex physiological communication between different body systems, and it is necessary for the optimal equilibrium and functioning of the organism. In particular, heart and kidney function is tightly connected, and...
Qiong Bai,Chun-Yan Su,Ai-Hua Zhang et al. Qiong Bai et al.
Background: In dialysis patients, loss of the normal gradient in arterial compliance, assessed by the pulse wave velocity (PWV) ratio, predicts all-cause mortality better than does carotid-femoral PWV (CF-PWV) alone. Howe...
Grazia Maria Virzì,Andrea Breglia,Ghada Ankawi et al. Grazia Maria Virzì et al.
Background: Cardiorenal syndrome (CRS) type 1 is characterized by a rapid worsening of cardiac function that leads to acute kidney injury (AKI). This study evaluated the role of lipopolysaccharide (LPS) in the development...
Liana Xhakollari,Margret Leosdottir,Martin Magnusson et al. Liana Xhakollari et al.
Background: Renal dysfunction is an established risk factor for cardiovascular disease, but early disease states in both organs are poorly studied. Object...
Dana V Rizk,Arnold L Silva,Pablo E Pergola et al. Dana V Rizk et al.
Background: Treatment with bardoxolone methyl (Bard) in a multinational phase 3 trial, Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes (BEACON), resulted in increases in estimated...
Melanie P Chin,Shannon Rich,Angie Goldsberry et al. Melanie P Chin et al.
Background: Bardoxolone methyl has been shown to increase eGFR in several clinical trials, including a phase 3 trial in patients with type 2 diabetes and stage 4 CKD (BEACON), which was terminated early due to an increase...
Krishnaswami Vijayaraghavan,Peter A McCullough,Bhupinder Singh et al. Krishnaswami Vijayaraghavan et al.
Background: Rates of cardiometabolic-renal disease are extremely high among South Asians (India, Pakistan, Bangladesh, Sri Lanka, Bhutan, the Maldives, and Nepal) residing in their home countries and worldwide. The Cardio...